A new drug candidate may be the first capable of halting the devastating mental decline of Alzheimer's disease, based on the findings of a study published today in PLoS One.
4.8 / 5 (17) |
0
|
If you're balding and want your hair to grow back, then here is some good news. A new research report appearing online in The FASEB Journal shows how the FDA-approved glaucoma drug, bimatoprost, causes human hair to reg ...
5 / 5 (16) |
0
|
(Medical Xpress) -- Most everyone that has been keeping abreast of world events knows that the clock is ticking on antibiotics; bacteria have been slowly developing a resistance and development of new antibiotics ...
4.7 / 5 (15) |
10
|
(Medical Xpress)—Professor Mark Kendall of the University of Queensland, Australia, has announced at this year's TEDGLobal Conference that a skin patch he and colleagues have developed will soon begin field ...
4.4 / 5 (13) |
0
|
(Medical Xpress) -- Researchers in Britain revealed Friday they are exploring whether the nightclubbers' drug ecstasy could be effective in treating blood cancers.
5 / 5 (11) |
2
|
(Medical Xpress) -- A new pharmaceutical program that many Britons might find literally hard to swallow, has been announced. Pharmacy chain Lloydspharmacy has partnered with American technology firm Proteus ...
4.1 / 5 (13) |
3
|
The FDA has announced the approval of Anascorp, the first drug designed to specifically treat and counteract the venomous stings of scorpions.
4.7 / 5 (11) |
0
|
(Medical Xpress)—A team of Italian researchers studying the contents of a small tin found aboard the wreck of a second century B.C. cargo ship claim its contents are pills meant to cure eye or skin ailments. ...
4.3 / 5 (11) |
2
|
Indian drugs giant Cipla said Friday it has slashed by up to 76 percent prices of generic medicines used to treat brain, lung and kidney cancer in what the company called a "humanitarian move".
4.9 / 5 (9) |
0
Indian pharmaceutical tycoon Yusuf Hamied revolutionised AIDS treatment more than a decade ago by supplying cut-price drugs to the world's poor -- and now he wants to do the same for cancer.
5 / 5 (6) |
0
(Medical Xpress)—New research from the University of Reading, The Royal Botanic Gardens, Kew and Imperial College London published on 10 September in the Proceedings of the National Academy of Sciences (PNAS) ...
5 / 5 (6) |
0
|
(Medical Xpress) -- Researchers in Chile have successfully tested a vaccine against meningococcus B, a strain of bacteria that causes meningococcal diseases, including one of the commonest forms of meningitis, a disease in ...
4.7 / 5 (6) |
0
|
(Medical Xpress) -- Two groups working independently have found that patients who suffer from nighttime teeth grinding, a condition known as nocturnal bruxism, found relief after being injected in their temple ...
4.5 / 5 (6) |
0
|
(Medical Xpress) -- Australian scientists have overcome one of the most pressing problems facing the pharmaceutical industry – how to create antibodies that are stable enough to meet stringent requirements necessary ...
4.3 / 5 (6) |
1
|
By reformulating the common cancer drug imatinib (Gleevec), researchers have eliminated morphine tolerance in rats – an important step toward improving the effectiveness of chronic pain management in patients, according ...
4.8 / 5 (5) |
3
|
